Brazilian Approval for COVID-19 Phase 2 Clinical Trial
Personalized Stem Cells announces Brazilian authorization for Phase 2 COVID-19 stem cell clinical trial licensed to Sorrento Therapeutics.
What are Mesenchymal Stem Cells?
Mesenchymal stem cells are multipotent adult stem cells that have multiple modes of action, making them a potential treatment option for a wide array of conditions.
Enrollment Complete for COVID-19 Stem Cell Clinical Trial
Personalized Stem Cells recently announced the COVID-19 stem cell clinical trial reached the target enrollment of ten patients.
More Positive Results in COVID-19 Clinical Trial
Personalized Stem Cells, Inc. announces additional positive results in COVID-19 FDA approved stem cell clinical trial licensed to Sorrento Therapeutics.
Knee Osteoarthritis Clinical Trial Update: FDA Submission and Results
We have officially submitted data to the FDA for our knee osteoarthritis clinical trial and the preliminary results look promising!
Using Stem Cell Therapy to Combat Osteoarthritis
Though there is still much to learn about the therapeutic effects of stem cell therapy, stem cell research has come a long way in the past few decades. Through a multitude of studies for a variety of conditions, researchers have made many important discoveries...
Stem Cell Sources: Adipose vs. Bone Marrow
While there are several sources of mesenchymal stem cells (MSCs), two of the most common sources include adipose tissue and bone marrow. At Personalized Stem Cells, we process adipose (fat) tissue to extract and concentrate MSCs for use in FDA-approved clinical...
Walking to Reduce Osteoarthritis Pain
Osteoarthritis (OA) is the most common form of arthritis. It is a degenerative disease in which the cartilage within a joint breaks down, causing changes in the surrounding bone. Common symptoms of OA include pain, stiffness, and reduced range of motion. While any...
First Patients Treated in COVID-19 Stem Cell Clinical Trial
In 2020, Personalized Stem Cells developed and secured FDA approval for a COVID-19 stem cell clinical trial. In October of last year, we announced that we out-licensed our allogeneic stem cell program, including the COVID-19 therapy, to Sorrento Therapeutics....
A Long and Winding Road: Meet PSC President and COO Mike Dale
Mike Dale is President and Chief Operating Officer of Personalized Stem Cells, Inc. (PSC), and co-founder of our parent company, VetStem Biopharma. Mike’s journey is not the typical biotech career path. In the 1970’s Mike had no scientific or biotech aspirations or...